10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

Andrew DJ Pearson; Delphine Heenen; Pamela R. Kearns; Anne Goeres; Lynley V. Marshall; Patricia Blanc; Gilles Vassal

doi:10.1016/S1470-2045(18)30105-0

10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

Andrew DJ Pearson, Delphine Heenen, Pamela R. Kearns, Anne Goeres, Lynley V. Marshall, Patricia Blanc, Gilles Vassal

Résultats de recherche: Contribution à un journal › !!Comment/debate

20 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	285-287
Nombre de pages	3
journal	The Lancet Oncology
Volume	19
Numéro de publication	3
Les DOIs	https://doi.org/10.1016/S1470-2045(18)30105-0
état	Publié - 1 mars 2018

Accès au document

10.1016/S1470-2045(18)30105-0

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{040890fe789947a181e8946b2a0b3b1f,

title = "10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers",

author = "Pearson, {Andrew DJ} and Delphine Heenen and Kearns, {Pamela R.} and Anne Goeres and Marshall, {Lynley V.} and Patricia Blanc and Gilles Vassal",

year = "2018",

month = mar,

day = "1",

doi = "10.1016/S1470-2045(18)30105-0",

language = "English",

volume = "19",

pages = "285--287",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "3",

}

TY - JOUR

T1 - 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

AU - Pearson, Andrew DJ

AU - Heenen, Delphine

AU - Kearns, Pamela R.

AU - Goeres, Anne

AU - Marshall, Lynley V.

AU - Blanc, Patricia

AU - Vassal, Gilles

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85042621404&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30105-0

DO - 10.1016/S1470-2045(18)30105-0

M3 - Comment/debate

C2 - 29508745

AN - SCOPUS:85042621404

SN - 1470-2045

VL - 19

SP - 285

EP - 287

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 3

ER -